Supporting the Health Care Board's Expanded Oversight Responsibilities: A Challenge for the General Counsel
- December 01, 2021
- Michael W. Peregrine , McDermott Will & Emery LLP
One of the most significant, yet discreet, governance developments of the pandemic era has been the expansion of corporate directors’ oversight obligations. While fundamentally grounded in the events of the COVID-19 crisis, this expansion is ultimately more the byproduct of evolving third-party expectations that directors be attentive to a larger universe of issues than before. And it’s a notable shift, that will significantly impact on how directors perform their duty of care in the future.
ARTICLE TAGS
You must be logged in to access this content.